-

ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers

Cloud-based, innovative, AI-powered technologies enable the streamlined delivery of leading clinical services and scaled operations in advanced Imaging

CAMBRIDGE, Mass. & LOUISVILLE, Ky.--(BUSINESS WIRE)--ConcertAI's TeraRecon, a leader in integrating advanced imaging workflows with clinical AI, has announced an expanded partnership with 3DR® Labs, a leading provider of 3D medical image post-processing and clinically integrated AI services in the United States. This collaboration aims to enhance clinical service delivery for advanced imaging by expanding the range of domain-specific workflows and clinical AI technologies. As a result, it will benefit numerous hospitals across the country.

The foundation of this partnership is TeraRecon's new TRSubscription™ offering, which grants 3DR Labs access to a comprehensive suite of advanced visualization tools, AI-powered clinical applications, and cloud services, all under a unified model. By integrating clinical AI and cloud technologies, both companies aim to equip healthcare providers with the latest innovations in imaging diagnostics and surgical planning. Additionally, TeraRecon will become a founding member of 3DR's AI Labs, a vendor-agnostic services platform designed for universal workflow integration using AI.

“Our partnership with 3DR addresses critical industry challenges, including increased pressure on hospital resources, rising demand for complex imaging analysis services, and the need for practical AI applications with validated clinical benefits,” said Dhiraj Carumbaya, SVP & GM for ConcertAI’s TeraRecon business. “Our new technology subscription gives customers full access to a range of clinical applications to comprehensively deliver exceptional service across their imaging enterprise.”

The partnership will help transition 3DR's clinical operations to the Cloud, an integral component of the TRSubscription™. This migration will streamline the interaction between 3DR Labs and its hospital clients by enabling secure, cloud-based data transmission and remote visualization capabilities, enhancing 3DR Labs' ability to scale its services while maintaining the highest clinical quality and data security standards.

“As demand for advanced medical imaging analysis continues to grow, this partnership allows 3DR Labs to stay at the forefront of innovation,” said Mike Jackman, CEO of 3DR Labs. “High-quality, outsourced 3D medical imaging services and AI-enabled insights enhance our ability to serve our hospital partners efficiently. By leveraging TeraRecon’s technology and partnering to offer AI as-a-service, we can scale our operations to meet increasing clinical needs while maintaining our commitment to exceptional quality and service.”

TeraRecon's new TRSubscription™ introduces cutting-edge advancements in AI for image processing technologies and clinical workflows throughout the imaging enterprise. This solution enables 3DR Labs to reinforce its leadership in offering clinical services for medical imaging post-processing and innovative surgical planning for hospitals. Visit TeraRecon at ACC2025, booth 17009, to learn more.

About ConcertAI

ConcertAI is the leader in predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai™ technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers, and medical societies. TeraRecon provides advanced radiological image visualizations and clinical AI decision augmentation solutions for MRI and CT. CancerLinQ® is an initiative of ConcertAI, providing oncology providers with ASCO-aligned automated QOPI and ASCO Certified® quality solutions and SmartLinQ™ analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. For more information, visit us at concertai.com.

About 3DR Labs

Headquartered in Louisville, Kentucky, 3DR Labs, LLC provides round-the-clock access to more than 250 expert radiologic technologists, cutting-edge imaging software, and advanced clinical AI workflow solutions. 3DR’s AI Labs, a vendor-agnostic services platform, connects imaging departments to a gateway of 3D workflow automation, delivering quality, speed, and efficiency within medical imaging systems. Founded in 2005, 3DR Labs provides services to over a thousand hospital imaging departments, stand-alone imaging centers, and radiology practices. Turnaround times for CT and MRI exams are guaranteed within hours or even minutes. For more information, please visit https://3drlabs.com/.

Contacts

ConcertAI


Release Versions

Contacts

Social Media Profiles
More News From ConcertAI

ConcertAI’s TeraRecon DETECT™ Helps Identify Opportunities to Optimize AI Imaging Reimbursement Workflows, Expanding Patient Access to the Most Advanced Care

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI’s TeraRecon, a leading provider of AI-empowered AV clinical workflows, visualization, and interoperability solutions, today announced TeraRecon DETECTTM, an AI-powered platform that helps identify opportunities to optimize reimbursement for multiple imaging biomarkers. With TeraRecon DETECTTM, patients get improved screening with more confident diagnoses, clinicians spend more time with their patients than on paperwork, and administrators can streaml...

ConcertAI Introduces TeraRecon AV™, Advancing AI-Powered Medical Imaging with New Structural Heart and SaaS Capabilities

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI’s TeraRecon, a leading provider of AI-empowered AV clinical workflows, visualization, and interoperability solutions, today announced TeraRecon AV™*, an advanced medical imaging visualization solution that enhances clinician diagnostic precision, streamlines processes, and improves patient care with AI-driven automation and new specialized clinical tools. Its secure, cloud-based infrastructure integrates seamlessly with any existing Radiology or Card...

ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences, today announced the appointment of Dr. Shaalan Beg as ConcertAI’s chief medical officer, oncology. In his new role, Dr. Beg will lead efforts to grow and engage the CancerLinQ community, ensuring the voices of practicing oncologists and their evolving patient needs are translated into actionable product development insights and...
Back to Newsroom